Patents by Inventor Su Cheng

Su Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method, device, and storage medium for evaluating speech quality
    Patent number: 10964337
    Abstract: A method, a device and a storage medium for evaluating speech quality include: receiving speech data to be evaluated; extracting evaluation features of the speech data to be evaluated; performing quality evaluation to the speech data to be evaluated according to the evaluation features of the speech data to be evaluated and a predetermined speech quality evaluation model, in which the speech quality evaluation model is an indication of a relationship between evaluation features of single-ended speech data and quality information of the single-ended speech data.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: March 30, 2021
    Assignee: Iflytek Co., Ltd.
    Inventors: Bing Yin, Si Wei, Guoping Hu, Su Cheng
  • Method, Device, and Storage Medium for Evaluating Speech Quality
    Publication number: 20190180771
    Abstract: A method, a device and a storage medium for evaluating speech quality include: receiving speech data to be evaluated; extracting evaluation features of the speech data to be evaluated; performing quality evaluation to the speech data to be evaluated according to the evaluation features of the speech data to be evaluated and a predetermined speech quality evaluation model, in which the speech quality evaluation model is an indication of a relationship between evaluation features of single-ended speech data and quality information of the single-ended speech data.
    Type: Application
    Filed: February 20, 2019
    Publication date: June 13, 2019
    Inventors: Bing Yin, Si Wei, Guoping Hu, Su Cheng
  • Targeted immunogens
    Publication number: 20040002455
    Abstract: The present invention provides reagents and methods for producing and utilizing targeted immunogens. In preferred embodiments, an immunogen is conjugated to an amino acid sequence that targets the immunogen to the MHC presentation pathway. Using the reagents and methods provided herein, immunization protocols may be enhanced resulting in increased immunity of the host.
    Type: Application
    Filed: January 29, 2003
    Publication date: January 1, 2004
    Applicants: Aventis Pasteur, Ltd., Aventis Pharmaceuticals, Inc.
    Inventors: Robert Adam Uger, Danielle Salha, Brian Barber, Clarence C. Morse, Yong Guo, Su Cheng